Safety, Immunogenicity, and Mucosal Shedding of a Live, Oral HIV-1 Vaccine (rcAd26.MOS1.HIV-Env) in a Phase 1, First-in-Human Clinical Trial (R001)

AIDS RESEARCH AND HUMAN RETROVIRUSES(2016)

Cited 0|Views32
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined